ENTITY

Genedrive (GDR LN)

11
Analysis
Health Care • United Kingdom
Genedrive is a molecular diagnostics company that develops and commercializes a rapid, versatile, and easy-to-use point-of-need molecular diagnostics platform. This platform is used for the diagnosis of infectious diseases, genotyping, and pathogen detection. Their key products include the Genedrive MT-RNR1 ID Kit for preventing antibiotic-induced hearing loss in neonates and the Genedrive CYP2C19 ID Kit for personalized antiplatelet treatment in stroke patients. The company is headquartered in Manchester, United Kingdom, and was founded in 2000.
more
bullish•Genedrive
•27 Feb 2026 09:29•Issuer-paid

Hybridan Small Cap Feast: 19 February 2026

The AIM, FSE, and OTC listed exploration and development Company with projects in Greenland, Finland and Italy confirms that the SEC has approved...

Logo
Hybridan
122 Views
Share
bullish•Verici Dx
•18 Aug 2026 18:04•Issuer-paid

Verici Dx Plc - Hybridan Small Cap Feast: 11 August 2026

The Company that develops mixed-signal, RF and microwave semiconductors for global communications markets updated on trading before holding its AGM...

Logo
Hybridan
97 Views
Share
bullish•Sound Energy
•11 Aug 2026 19:03•Issuer-paid

Sound Energy plc - Hybridan Small Cap Feast: 4 August 2026

The designer, developer and supplier of interior components to the global automotive industry updates on Interim Trading to June 2026.

Logo
Hybridan
102 Views
Share
bullish•Amaroq
•10 Aug 2026 18:01•Issuer-paid

Hybridan Small Cap Feast: 3 August 2026

The technology and services provider specialising in end-to-end solutions for the branded merchandise and promotional products industry announced...

Logo
Hybridan
120 Views
Share
bullish•Acuity RM Group
•20 Jul 2026 21:51•Issuer-paid

Hybridan Small Cap Feast: 13 July 2026

The software group specialising in the cybersecurity sector of the Governance, Risk and Compliance market announces the first sale of its new...

Logo
Hybridan
114 Views
Share
x